Most Anticipated Trial Results Regarding Biomarkers in RCC

Most Anticipated Trial Results Regarding Biomarkers in RCC

obr

7 months
416 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
Report 0 0
Category:
Description:
Tian Zhang , MD, Assistant Professor of Medicine, Duke Cancer Institute, explains the anticipated trial results involving I-O, TKIs and biomarkers in renal cell carcinoma (RCC).
Up Next Autoplay